These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 26927514

  • 1. Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma.
    Lee SH, Do SI, Lee HJ, Kang HJ, Koo BS, Lim YC.
    Lab Invest; 2016 May; 96(5):508-16. PubMed ID: 26927514
    [Abstract] [Full Text] [Related]

  • 2. SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma.
    Lee SH, Oh SY, Do SI, Lee HJ, Kang HJ, Rho YS, Bae WJ, Lim YC.
    Br J Cancer; 2014 Nov 25; 111(11):2122-30. PubMed ID: 25321191
    [Abstract] [Full Text] [Related]

  • 3. Targeting HIF-1α/NOTCH1 pathway eliminates CD44+ cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma.
    Byun JY, Huang K, Lee JS, Huang W, Hu L, Zheng X, Tang X, Li F, Jo DG, Song X, Huang C.
    Oncogene; 2022 Feb 25; 41(9):1352-1363. PubMed ID: 35013621
    [Abstract] [Full Text] [Related]

  • 4. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
    Lim YC, Kang HJ, Moon JH.
    Oral Oncol; 2014 Jul 25; 50(7):633-9. PubMed ID: 24835851
    [Abstract] [Full Text] [Related]

  • 5. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells.
    Moon JH, Lee SH, Koo BS, Kim JM, Huang S, Cho JH, Eun YG, Shin HA, Lim YC.
    Oral Oncol; 2020 Dec 25; 111():104948. PubMed ID: 32771963
    [Abstract] [Full Text] [Related]

  • 6. Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma.
    Muhammad N, Bhattacharya S, Steele R, Phillips N, Ray RB.
    Clin Cancer Res; 2017 Jun 15; 23(12):3120-3128. PubMed ID: 27965308
    [Abstract] [Full Text] [Related]

  • 7. Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
    Bae WJ, Koo BS, Lee SH, Kim JM, Rho YS, Lim JY, Moon JH, Cho JH, Lim YC.
    Br J Cancer; 2017 Dec 05; 117(12):1810-1818. PubMed ID: 29096401
    [Abstract] [Full Text] [Related]

  • 8. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
    Elkashty OA, Abu Elghanam G, Su X, Liu Y, Chauvin PJ, Tran SD.
    Carcinogenesis; 2020 Jun 17; 41(4):458-466. PubMed ID: 31742606
    [Abstract] [Full Text] [Related]

  • 9. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY, Wong G, Earle C, Chen L.
    J Biol Chem; 2012 Sep 21; 287(39):32800-24. PubMed ID: 22847005
    [Abstract] [Full Text] [Related]

  • 10. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
    Kulsum S, Sudheendra HV, Pandian R, Ravindra DR, Siddappa G, R N, Chevour P, Ramachandran B, Sagar M, Jayaprakash A, Mehta A, Kekatpure V, Hedne N, Kuriakose MA, Suresh A.
    Mol Carcinog; 2017 Feb 21; 56(2):694-711. PubMed ID: 27380877
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
    Lee SH, Nam HJ, Kang HJ, Kwon HW, Lim YC.
    Eur J Cancer; 2013 Oct 21; 49(15):3210-8. PubMed ID: 23876835
    [Abstract] [Full Text] [Related]

  • 14. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.
    Subramanian C, Kovatch KJ, Sim MW, Wang G, Prince ME, Carey TE, Davis R, Blagg BSJ, Cohen MS.
    Neoplasia; 2017 Dec 21; 19(12):1003-1011. PubMed ID: 29121598
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.
    Nör C, Zhang Z, Warner KA, Bernardi L, Visioli F, Helman JI, Roesler R, Nör JE.
    Neoplasia; 2014 Feb 21; 16(2):137-46. PubMed ID: 24709421
    [Abstract] [Full Text] [Related]

  • 17. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
    Keysar SB, Le PN, Miller B, Jackson BC, Eagles JR, Nieto C, Kim J, Tang B, Glogowska MJ, Morton JJ, Padilla-Just N, Gomez K, Warnock E, Reisinger J, Arcaroli JJ, Messersmith WA, Wakefield LM, Gao D, Tan AC, Serracino H, Vasiliou V, Roop DR, Wang XJ, Jimeno A.
    J Natl Cancer Inst; 2017 Jan 21; 109(1):. PubMed ID: 27634934
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.